Correlation Between Atea Pharmaceuticals and Equillium

By analyzing existing cross correlation between Atea Pharmaceuticals and Equillium, you can compare the effects of market volatilities on Atea Pharmaceuticals and Equillium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atea Pharmaceuticals with a short position of Equillium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atea Pharmaceuticals and Equillium.

Specify exactly 2 symbols:

Can any of the company-specific risk be diversified away by investing in both Atea Pharmaceuticals and Equillium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atea Pharmaceuticals and Equillium into the same portfolio, which is an essential part of the fundamental portfolio management process.

Diversification Opportunities for Atea Pharmaceuticals and Equillium

  Correlation Coefficient
Atea Pharmaceuticals

Weak diversification

The 3 months correlation between Atea Pharmaceuticals and Equillium is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Atea Pharmaceuticals and Equillium in the same portfolio assuming nothing else is changed. The correlation between historical prices or returns on Equillium and Atea Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atea Pharmaceuticals are associated (or correlated) with Equillium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equillium has no effect on the direction of Atea Pharmaceuticals i.e., Atea Pharmaceuticals and Equillium go up and down completely randomly.

Pair Corralation between Atea Pharmaceuticals and Equillium

Given the investment horizon of 90 days Atea Pharmaceuticals is expected to generate 6.28 times less return on investment than Equillium. But when comparing it to its historical volatility, Atea Pharmaceuticals is 5.94 times less risky than Equillium. It trades about 0.04 of its potential returns per unit of risk. Equillium is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  403.00  in Equillium on June 29, 2021 and sell it today you would earn a total of  270.00  from holding Equillium or generate 67.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
ValuesDaily Returns

Atea Pharmaceuticals  vs.  Equillium

 Performance (%) 
Atea Pharmaceuticals 
 Atea Pharmaceuticals Performance
8 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Atea Pharmaceuticals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating forward indicators, Atea Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Atea Pharmaceuticals Price Channel

 Equillium Performance
5 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Equillium are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Equillium displayed solid returns over the last few months and may actually be approaching a breakup point.

Equillium Price Channel

Atea Pharmaceuticals and Equillium Volatility Contrast

 Predicted Return Density 

Pair Trading with Atea Pharmaceuticals and Equillium

The main advantage of trading using opposite Atea Pharmaceuticals and Equillium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atea Pharmaceuticals position performs unexpectedly, Equillium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will offset losses from the drop in Equillium's long position.
The idea behind Atea Pharmaceuticals and Equillium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Content Syndication
Quickly integrate customizable finance content to your own investment portal